CYTK
Price
$37.39
Change
-$3.13 (-7.72%)
Updated
Apr 4, 04:11 PM (EDT)
Capitalization
4.8B
27 days until earnings call
NNVC
Price
$1.09
Change
-$0.05 (-4.39%)
Updated
Apr 4, 04:53 PM (EDT)
Capitalization
17.83M
46 days until earnings call
Ad is loading...

CYTK vs NNVC

Header iconCYTK vs NNVC Comparison
Open Charts CYTK vs NNVCBanner chart's image
Cytokinetics
Price$37.39
Change-$3.13 (-7.72%)
Volume$2.55K
Capitalization4.8B
NanoViricides
Price$1.09
Change-$0.05 (-4.39%)
Volume$200
Capitalization17.83M
CYTK vs NNVC Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. NNVC commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and NNVC is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CYTK: $40.52 vs. NNVC: $1.14)
Brand notoriety: CYTK and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 147% vs. NNVC: 23%
Market capitalization -- CYTK: $4.8B vs. NNVC: $17.83M
CYTK [@Biotechnology] is valued at $4.8B. NNVC’s [@Biotechnology] market capitalization is $17.83M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileNNVC’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • NNVC’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than NNVC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while NNVC’s TA Score has 4 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 6 bearish.
  • NNVC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NNVC is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -5.75% price change this week, while NNVC (@Biotechnology) price change was -5.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.19%. For the same industry, the average monthly price growth was -17.05%, and the average quarterly price growth was -18.79%.

Reported Earning Dates

CYTK is expected to report earnings on May 01, 2025.

NNVC is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.8B) has a higher market cap than NNVC($17.8M). CYTK YTD gains are higher at: -13.861 vs. NNVC (-20.280). NNVC has higher annual earnings (EBITDA): -8.59M vs. CYTK (-493.48M). CYTK has more cash in the bank: 1.08B vs. NNVC (3.96M). NNVC has less debt than CYTK: NNVC (1.5M) vs CYTK (789M). CYTK has higher revenues than NNVC: CYTK (18.5M) vs NNVC (0).
CYTKNNVCCYTK / NNVC
Capitalization4.8B17.8M26,955%
EBITDA-493.48M-8.59M5,743%
Gain YTD-13.861-20.28068%
P/E RatioN/AN/A-
Revenue18.5M0-
Total Cash1.08B3.96M27,185%
Total Debt789M1.5M52,600%
FUNDAMENTALS RATINGS
CYTK vs NNVC: Fundamental Ratings
CYTK
NNVC
OUTLOOK RATING
1..100
8373
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
31
Undervalued
PROFIT vs RISK RATING
1..100
64100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
8377
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NNVC's Valuation (31) in the Biotechnology industry is significantly better than the same rating for CYTK (100). This means that NNVC’s stock grew significantly faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for NNVC (100). This means that CYTK’s stock grew somewhat faster than NNVC’s over the last 12 months.

NNVC's SMR Rating (98) in the Biotechnology industry is in the same range as CYTK (100). This means that NNVC’s stock grew similarly to CYTK’s over the last 12 months.

NNVC's Price Growth Rating (77) in the Biotechnology industry is in the same range as CYTK (83). This means that NNVC’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for NNVC (100). This means that CYTK’s stock grew significantly faster than NNVC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKNNVC
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 16 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HCSG10.13-0.09
-0.88%
Healthcare Services Group
ETR85.06-1.55
-1.79%
Entergy Corporation
SLI1.26-0.05
-3.82%
Standard Lithium Ltd
GFF69.66-5.31
-7.08%
Griffon Corp
RVYL0.87-0.08
-8.16%
Ryvyl